Insider · CIK 0001759855

Parsons James T.

Reports to the SEC for 3 companies · MINNEAPOLIS, MN

sec.gov

Transactions

Companies

Filings

CIK

0001759855

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-01	ONCYONCOLYTICS BIOTECH INC · Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2026-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+51.2K sh	—	—	51,189
2026-03-11	ONCYONCOLYTICS BIOTECH INCP Purchase	Director	PPurchase	+10K sh	$1.03	+$10.3K	41,849
2026-01-02	DMACDiaMedica Therapeutics Inc.A Award	Director	AAward	+10.1K sh	$8.42	+$85K	97,949
2025-11-21	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−12K sh	—	—	0
2025-11-21	DMACDiaMedica Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$2.20	+$26.4K	87,854
2025-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+40.7K sh	—	—	40,739
2025-01-02	DMACDiaMedica Therapeutics Inc.A Award	Director	AAward	+15.9K sh	$5.34	+$85K	75,854
2025-01-02	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,287 sh	—	—	4,287
2024-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+28.5K sh	—	—	28,472
2024-01-02	DMACDiaMedica Therapeutics Inc.A Award	Director	AAward	+21.4K sh	$2.80	+$60K	59,937
2023-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+17K sh	—	—	16,968
2022-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,222
2022-01-03	DMACDiaMedica Therapeutics Inc.A Award	Director	AAward	+16.8K sh	$3.58	+$60K	38,509
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−180K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−94.8K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−59.9K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−5,761 sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−36.2K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−24.4K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−30.2K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−30.2K sh	—	—	0
2021-07-15	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,393 sh	—	—	9,393
2021-01-08	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+8,505 sh	$7.24	+$61.6K	8,505
2021-01-08	Trillium Therapeutics Inc.S Sale	Chief Financial Officer	SSale	−8,505 sh	$15.79	−$134K	0
2021-01-08	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−8,505 sh	—	—	5,761
2021-01-01	DMACDiaMedica Therapeutics Inc.A Award	Director	AAward	+7,745 sh	$8.23	+$63.7K	21,947
2020-06-01	DMACDiaMedica Therapeutics Inc.A Award	Director	AAward	+8,102 sh	$4.59	+$37.2K	14,202
2020-06-01	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.3K sh	—	—	13,306
2019-06-24	DMACDiaMedica Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+13K sh	—	—	12,950
2018-12-11	DMACDiaMedica Therapeutics Inc.P Purchase	Director	PPurchase	+2,250 sh	$4.00	+$9,000	6,100

Recent filings

Accepted (ET)
Jun 34
Parsons James T.0001493152-26-027089
SEC(opens sec.gov)
Jun 34
Parsons James T.0001759855-26-000004
SEC(opens sec.gov)
Mar 134
Parsons James T.0001493152-26-009983
SEC(opens sec.gov)
Jan 64
Parsons James T.0001759855-26-000002
SEC(opens sec.gov)
Nov 254
Parsons James T.0001759855-25-000006
SEC(opens sec.gov)
Jun 34
Parsons James T.0001437749-25-019293
SEC(opens sec.gov)
Jan 34
Parsons James T.0001235802-25-000005
SEC(opens sec.gov)
Jun 34
Parsons James T.0001235802-24-000047
SEC(opens sec.gov)
Jan 24
Parsons James T.0001235802-24-000002
SEC(opens sec.gov)
Jun 24
Parsons James T.0001235802-23-000058
SEC(opens sec.gov)
Jun 24
Parsons James T.0001235802-22-000072
SEC(opens sec.gov)
Jan 34
Parsons James T.0001235802-22-000002
SEC(opens sec.gov)
Nov 194
Parsons James T.0001104659-21-141747
SEC(opens sec.gov)

Companies

Address

301 CARLSON PARKWAY SUITE 210

MINNEAPOLIS, MN, 55305